DOT Changes Drug Testing List
The U.S. Department of Transportation (DOT) recently issued a final rule that expands the DOT’s current drug testing panel to include some semi-synthetic opioids:
- Hydrocodon – Trade names Norco, Vicodin, Lortab, Vicoprofen and Riboxen
- Hydromorphone – Trade name Dilasudid
- Oxymorphone – Trade name Numorphan
- Oxycodone – Trade name Eucodal
DOT-regulated employers will be required to test for these highly abused opioids beginning on Jan. 1, 2018.
This change was made to enhance safety, prevent opioid abuse and combat the growing opioid epidemic in the United States. Currently, the DOT requires drug testing of safety-sensitive employees in the transportation industries.
“The opioid crisis is a threat to public safety when it involves safety-sensitive employees involved in the operation of any kind of vehicle or transport,” said Secretary Elaine L. Chao. “The ability to test for a broader range of opioids will advance transportation safety significantly and provide another deterrence to opioid abuse, which will better protect the public and ultimately save lives.”